Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1160755
Max Phase: Preclinical
Molecular Formula: C19H25N8O9P
Molecular Weight: 540.43
Molecule Type: Small molecule
Associated Items:
ID: ALA1160755
Max Phase: Preclinical
Molecular Formula: C19H25N8O9P
Molecular Weight: 540.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1ccn(C2C[C@@H](O)[C@@H](COP(=O)(O)O[C@H]3[C@@H](CO)OC[C@@H]3n3cnc4c(N)ncnc43)O2)c(=O)n1
Standard InChI: InChI=1S/C19H25N8O9P/c20-13-1-2-26(19(30)25-13)14-3-10(29)12(35-14)6-34-37(31,32)36-16-9(5-33-11(16)4-28)27-8-24-15-17(21)22-7-23-18(15)27/h1-2,7-12,14,16,28-29H,3-6H2,(H,31,32)(H2,20,25,30)(H2,21,22,23)/t9-,10+,11+,12+,14?,16+/m0/s1
Standard InChI Key: UHVMTOAALPBXGE-ZNUXUSHFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 540.43 | Molecular Weight (Monoisotopic): 540.1482 | AlogP: -1.67 | #Rotatable Bonds: 8 |
Polar Surface Area: 245.21 | Molecular Species: ACID | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.84 | CX Basic pKa: 5.09 | CX LogP: -5.05 | CX LogD: -5.23 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.20 | Np Likeness Score: 1.14 |
1. Nair V, Pal S.. (2004) Resistance towards exonucleases of dinucleotides with stereochemically altered internucleotide phosphate bonds., 14 (1): [PMID:14684345] [10.1016/j.bmcl.2003.07.034] |
Source(1):